openPR Logo
Press release

Glaucoma Treatment Market : Rising Geriatric Population And Healthcare Expenditure Will Drive The Glaucoma Treatment Market

11-18-2016 11:00 AM CET | Health & Medicine

Press release from: Transparecny Market Research

Glaucoma Treatment Market : Rising Geriatric Population

Glaucoma is a chronic, degenerative, permanent disorder whose rate increases essentially with age rather than causing immediate blindness. According to a survey of WHO, Glaucoma is the second most common cause of blindness affecting the population worldwide after cataract (47.9%). In general, Glaucoma occurs as after effects of increased intraocular pressure (IOP) brought about by an abnormality or malfunctioning of the eye drainage system. The normal IOP is in between the range of 19-21 inches of Hg but when the pressure exceed than this range, it causes compression of retina and optic nerve causing progressive, leading to permanent loss of visual perception if not treated on time. The most common types of glaucoma are open angle glaucoma and closed angle glaucoma. As per International Council of Ophthalmology report, closed angle and open angle glaucoma individually account for about half of all glaucoma cases and are the major cause of irreversible vision globally. For glaucoma, everyone is at risk from babies to senior citizens. The market for glaucoma treatment has been growing rapidly since last few years due to increasing number of people with glaucoma and introduction of innovative treatments. In past few years different therapies are introduced including, laser therapy, photodynamic therapy, IOPtiMa therapy along with eye drops and pills which will grow the glaucoma treatment market in coming years.

The driver of glaucoma treatment market includes rising geriatric population and healthcare expenditure. It has been stated that glaucoma is more prevalent among the people above age of 60 and globally growing geriatric population is expected as the main reason for growth of glaucoma treatment market in forecast period of 2016-2024. Cases of congenital glaucoma are increasing and main reason for this problem is changing lifestyle and habits. According to Glaucoma Research Foundation survey, approximately one out of 10,000 babies born with glaucoma in United States. Improved medical coverage and new innovation in glaucoma drugs and treatments are also the key factors which are expected to drive the growth of glaucoma treatment market.

For Any Queries Get Solutions With A PDF Sample : http://bit.ly/2g4p8DO

Global glaucoma treatment market is segmented on the basis of drug class, therapy used, disease indication, end users and region. Based on drug class, glaucoma treatment market further segmented into Prostaglandin Analogs (PGAs), Alpha Agonist, Beta Blockers, Cholinergic, Carbonic Anhydrase Inhibitors, and Combined Medications. Prostaglandin Analogs drug segment is expected to account for the largest share of the global glaucoma treatment market as new innovative drugs are coming are in this segment also on the basis of treatment, also these drugs are widely prescribed drugs.

In the basis of therapy, glaucoma treatment market is further segmented into Glaucoma surgery, Laser iridotomy, Laser trabeculoplasty, Aqueous shunt surgery and Peripheral iridectomy. Glaucoma surgery segment is expected to have highest share of glaucoma treatment market. Increasing geriatric population and trust buildup on surgery treatment as compared to laser treatments are the factors contributing towards the growth of this segment in glaucoma treatment market in coming years.

On the basis of disease indication, glaucoma treatment market is further segmented into angle closure glaucoma (ACG), open angle glaucoma (OAG), secondary glaucoma, congenital glaucoma and other. Other less common types of glaucoma includes pigmentary glaucoma, pseudoexfoliation glaucoma and normal-tension glaucoma (NTG). The most common types of glaucoma are open angle glaucoma (OAG) and closed angle glaucoma (CAG). As per International Council of Ophthalmology report, closed angle and open angle glaucoma individually account for about half of all glaucoma cases also they are responsible for the major cause of irreversible vision worldwide. Therefore, Open angle glaucoma and angle closure glaucoma segments are expected to account for highest share of glaucoma treatment market in the forecast period of 2016-2024. On the basis of end users, glaucoma treatment market is segmented into hospitals, specialized clinics, ambulatory surgery centers, hospital pharmacies, drug stores and retail pharmacies.

Geographically, the global glaucoma treatment market is divided into five key regions, North America, Europe, Asia-Pacific, Latin America and the Middle East, and Africa. In terms of geography, North America is expected to account for the extensive market share for glaucoma treatment market where the number of glaucoma patients is the highest. Moreover, the Asian market is expected to become a huge potential market for glaucoma treatment in the forecast period, as it is expected to grow at fastest CAGR among all other regions.

Major players in glaucoma treatment market includes Novartis AG, Allergan, Merck & Co., Inc., Akorn, Inc., Bausch & Lomb Incorporated, Teva Pharmaceuticals, Pfizer and Santen.

About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Glaucoma Treatment Market : Rising Geriatric Population And Healthcare Expenditure Will Drive The Glaucoma Treatment Market here

News-ID: 384370 • Views:

More Releases from Transparecny Market Research

Snack Food Packaging Market worth $25.8 billion by 2031, growing at a CAGR of 4.4% - Exclusive Report by TMR
Snack Food Packaging Market worth $25.8 billion by 2031, growing at a CAGR of 4. …
The global Snack Food Packaging Market has been sailing through robust waters, witnessing a valuation of US$ 17.6 Bn 2022. As we set our sights on the horizon, the market is poised to embark on a journey of steady growth, with a projected Compound Annual Growth Rate (CAGR) of 4.4% from 2023 to 2031. By the end of 2031, the industry is expected to anchor at an impressive US$ 25.8
Extended Text Labels Market to Rise at Over 5% CAGR By 2025
Extended Text Labels Market to Rise at Over 5% CAGR By 2025
The global Extended Text Labels Market is estimated to flourish at a CAGR of 5% from 2023 to 2031. The global Extended Text Labels Market has been sailing through robust waters, witnessing a valuation of US$ 66.2 Bn 2022. As we set our sights on the horizon, the market is poised to embark on a journey of steady growth, with a projected Compound Annual Growth Rate (CAGR) of 6.8% from 2023
Single Dose Packaging Market worth $112.1 billion by 2031, growing at a CAGR of 6.8% - Exclusive Report by TMR
Single Dose Packaging Market worth $112.1 billion by 2031, growing at a CAGR of …
The global Single Dose Packaging Market has been sailing through robust waters, witnessing a valuation of US$ 66.2 Bn 2022. As we set our sights on the horizon, the market is poised to embark on a journey of steady growth, with a projected Compound Annual Growth Rate (CAGR) of 6.8% from 2023 to 2031. By the end of 2031, the industry is expected to anchor at an impressive US$ 112.1
Blister Pack Pharmaceutical Products Market 2024 Opportunity Assessment, Size, Growth Rate & Forecast To 2030
Blister Pack Pharmaceutical Products Market 2024 Opportunity Assessment, Size, G …
The global Blister Pack Pharmaceutical Products Market is estimated to flourish at a CAGR of 6.7% from 2024 to 2030. The overall Blister Pack Pharmaceutical Products industry delivers an in-depth systematic framework and competitive outlook of the Blister Pack Pharmaceutical Products Market from a worldwide perspective. The report starts with a summary of the market, chain structure, and the past as well as current market size. Also, the growth opportunities prevalent

All 5 Releases


More Releases for Glaucoma

Micro-Invasive Glaucoma Implants Micro-Invasive Glaucoma Implants
Global Micro-Invasive Glaucoma Implants Market Definition: Micro-invasive glaucoma implants is performed for the treatment of the open- angle glaucoma and is done through an ab- interno approach. It is very safe and provides faster recovery as compared to the traditional methods. They usually lower the intraocular by increasing the flow or reducing the production of the aqueous humor. Increasing cases of the glaucoma worldwide is the major factor fueling the
Glaucoma – Epidemiology Insights (2016-2028)
Glaucoma can be described as a group of diseases characterized by cupping of the optic nerve head and visual-field damage. These diseases differ from each other in terms of their causes, risk factors, demographics, symptoms, duration, treatment, and prognosis. Download the sample report @ https://www.pharmaproff.com/request-sample/1159 The common identifiable features for all forms of glaucoma are loss of retinal ganglion cells, thinning of the retinal nerve fiber layer, and cupping of the
Market Spotlight: Glaucoma
Boston, MA ReportsWorldwide has announced the addition of a new report title Market Spotlight: Glaucoma to its growing collection of premium market research reports. Glaucoma is not just one eye disease, but a group of eye conditions resulting in optic nerve damage, which may cause loss of vision and blindness. In glaucoma, damage to the optic nerve is usually caused by elevated intraocular pressure (IOP). IOP rises when passages that allow fluid
North America Glaucoma Therapeutics Market grows with growing awareness regardin …
Glaucoma Therapeutics Market: Scope and Methodology The research is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue of the major glaucoma therapeutics market in the near future. Primary research formed the bulk of our research efforts with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders. Secondary research involved study
Glaucoma Surgery Devices Market 2016: Glaucoma Systems, Glaucoma Laser Devices
Latest industry research report on Glaucoma surgery devices are used in the glaucoma treating procedure. These procedures include both surgical and laser therapies performed on a patient. The cases of blindness due to glaucoma is on rise across the several countries. Furthermore, the demand for both technologically as well as advanced surgical equipment has resulted in the popularity of glaucoma surgery devices industry, worldwide. Sudden increase in the aging population and
Can yoga worsen glaucoma?
Patients with glaucoma are encouraged to exercise and lead healthy and active lifestyle, but should avoid activities that increase the eye pressure and damage the optic nerve. Push-ups and heavy weight lifting are not advisable, so is certain yoga postures in which the head is facing downward. Previous studies have investigated only headstand position which showed a remarkable two-fold increase in eye pressure. However, a new research carried out at